113
Views
0
CrossRef citations to date
0
Altmetric
Response to Letter

Effect of Exogenous Hormones and Reproductive Factors in Female Melanoma: A Meta-Analysis [Response to Letter]

, , , , & ORCID Icon
Pages 511-512 | Published online: 26 Apr 2022

References

  • Chiavarini M, Naldini G, Giacchetta I, Fabiani R. Effect of exogenous hormones and reproductive factors in female melanoma: a meta-analysis [Letter]. Clin Epidemiol. 2022;14:211–212. doi:10.2147/CLEP.S356205
  • Botteri E, Stoer NC, Weiderpass E, Pukkala E, Ylikorkala O, Lyytinen H. Menopausal hormone therapy and risk of melanoma: a nationwide register-based study in Finland. Cancer Epidemiol Biomarkers Prev. 2019;28:1857–1860. doi:10.1158/1055-9965.EPI-19-0554
  • Brinton LA, Moghissi KS, Scoccia B, et al. Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril. 2015;104:980–988. doi:10.1016/j.fertnstert.2015.06.045
  • Sun Q, Sun H, Cong L, Zheng Y, Wu N, Cong X. Effects of exogenous hormones and reproductive factors on female melanoma: a meta-analysis. Clin Epidemiol. 2020;12:1183–1203. doi:10.2147/CLEP.S273566
  • Behrens T, Kaerlev L, Cree I, et al. Hormonal exposures and the risk of uveal melanoma. Cancer Causes Control. 2010;21:1625–1634. doi:10.1007/s10552-010-9591-9
  • Vessey MP, Painter R, Powell J. Skin disorders in relation to oral contraception and other factors, including age, social class, smoking and body mass index. Findings in a large cohort study. Br J Dermatol. 2000;143:815–820. doi:10.1046/j.1365-2133.2000.03782.x
  • Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004. Br J Cancer. 2006;95:385–389. doi:10.1038/sj.bjc.6603260
  • Hannaford PC, Villard-Mackintosh L, Vessey MP, Kay CR. Oral contraceptives and malignant melanoma. Br J Cancer. 1991;63:430–433. doi:10.1038/bjc.1991.99
  • Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner’s oral contraception study. BMJ. 2007;335(7621):651. doi:10.1136/bmj.39289.649410.55
  • Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. Uveal melanoma, hormonal and reproductive factors in women. Cancer Res. 1991;51:1370–1372.
  • Hartge P, Tucker MA, Shields JA, Augsburger J, Hoover RN, Fraumeni JF Jr. Case-control study of female hormones and eye melanoma. Cancer Res. 1989;49:4622–4625.
  • Gallagher RP, Elwood JM, Hill GB. Risk factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Recent Results Cancer Res. 1986;102:38–55.
  • Green A, Bain C. Hormonal factors and melanoma in women. Med J Aust. 1985;142:446–448. doi:10.5694/j.1326-5377.1985.tb113446.x
  • Kay CR. Malignant melanoma and oral contraceptives. Br J Cancer. 1981;44:479. doi:10.1038/bjc.1981.211